DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



How Lidocaine Affects Outcomes In Orthopedic Surgery Patients

Information source: Cedars-Sinai Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: General Anesthesia; Surgeries Requiring A Minimum One Day Hospitalization; Elderly

Intervention: Lidocaine (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Cedars-Sinai Medical Center

Official(s) and/or principal investigator(s):
Roya Yumul, MD, PhD, Principal Investigator, Affiliation: Cedars-Sinai Medical Center

Overall contact:
Roya Yumul, MD, PhD, Phone: (310) 423-5841, Email: roya.yumul@cshs.org

Summary

This study will evaluate the effect of intraoperative lidocaine infusion on postoperative orientation and concentration in elderly patients having general anesthesia for orthopedic surgeries requiring a minimum 2 days hospitalization. This study will also aim to determine whether intraoperative lidocaine infusion during general anesthesia improves recovery and patient outcome, as well as to determine whether lidocaine infusion decreases postoperative opioid (pain medication) usage.

Clinical Details

Official title: The Effects Of Lidocaine Infusion On The Recovery Of Cognitive Function Following General Anesthesia In Elderly Patients Undergoing Orthopedic Surgeries Requiring A Minimum Two Day Hospitalization

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver)

Primary outcome: Post-operative cognitive function

Secondary outcome:

Postoperative pain

Opioid consumption obtained from the recorded data

Postoperative nausea and vomiting using a Verbal Rating Scale

Return to normal activities of daily living using follow up questionnaires Return to normal activities of daily living using follow up questionnaires

Patient satisfaction using a verbal rating scale from 0 to 100

Hospital stay

Detailed description: Advances in surgical techniques and anesthetic care have resulted in a substantial reduction in peri-operative morbidity and mortality in the elderly. However, post-operative cognitive dysfunction (POCD), as well as episodic post-operative delirium, are still recognized as significant complications following surgery in the elderly. Post-operative cognitive dysfunction is characterized by impairment of memory, concentration, language, comprehension, and social integration. Conversely, post-operative delirium is characterized by intermittent, short-term impaired cognition, disorientation, and abnormalities in memory and perception, which has been shown to lead to increased morbidity and mortality, delayed functional recovery, and prolonged hospital stays. Elderly patients are particularly sensitive to the central nervous system effects of many peri-anesthetic drugs, including benzodiazepines, barbiturates, opioids, and volatile anesthetics, which may play a role in POCD and consequent patient outcomes. Randomized clinical trials have demonstrated no difference in the recovery of cognitive function between commonly used volatile anesthetic agents. Several simple, bedside tests are available to assess cognitive function and differentiate between cognitive dysfunction and an episode of delirium. The Confusion Assessment Method (CAM) is a standardized rating of delirium that has been validated and has high inter-observer reliability. The CAM criteria are the most commonly used method for diagnosing delirium in hospitalized patients. The Mini-Mental Status Examination (MMSE) and the Abbreviated Mental Test are tools used to assess cognitive function at the bedside. Lidocaine is one of the most commonly used sodium-channel blockers in the medical armamentarium. It has long been used for its local anesthetic and anti-arrhythmic properties, and has been studied as an adjunct to general anesthesia. While lidocaine is cardio-toxic in excessive doses, the therapeutic and toxic levels are well-documented and wide, making lidocaine a drug with a favorable safety profile. Randomized clinical trials have shown perioperative lidocaine infusions to decrease postoperative pain scores, reduce postoperative opioid requirements, shortens hospital stays, improves postoperative recovery and fatigue score when administered as an adjuvant during surgery. Lidocaine has analgesic, antihypertensive, and anti-inflammatory properties. To date, no clinical trials have been conducted to establish the relationship between lidocaine infusions and postoperative recovery, particularly cognitive function, in elderly orthopedic surgery patients. It is therefore the aim of this study to evaluate the effects of lidocaine infusion on postoperative cognitive function in elderly patients having general anesthesia for orthopedic surgery, and to assess whether intraoperative lidocaine infusion decreases postoperative opioid usage and improves recovery.

Eligibility

Minimum age: 65 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Scheduled to undergo orthopedic surgery under general anesthesia requiring a minimum

two-day hospitalization (e. g. THA, TKA, hardware removal)

- 65 years of age or older

- ASA Physical Classification I - IV

- Willingness and ability to sign an informed consent document

- English-speaking

Exclusion Criteria:

- Inability to consent or complete cognitive assessments

- Inability to use a PCA system

- Allergy to lidocaine or any other medication administered as part of this protocol

- Emergency surgery

Locations and Contacts

Roya Yumul, MD, PhD, Phone: (310) 423-5841, Email: roya.yumul@cshs.org

Cedars Sinai Medical Center, Los Angeles, California 90048, United States; Recruiting
Additional Information

Starting date: June 2011
Last updated: February 26, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017